The methylation levels of the HAND1 CpG site in CRC patients showed a sensitivity of 93.33% (95% CI, 70.18–99.66%) and a specificity of 80.00% (95% CI, 62.69–90.49%), with a cut-off > 1.57. The gene discussed is HAND1; the disease is colorectal carcinoma.